Medicare Enrolled

Dr. Mohammed Al-Qasmi, MD

Neurology · Bay City, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1900 COLUMBUS AVE, Bay City, MI 48708
9896673410
Registered in NPPES since 2006
NPI: 1629027479 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Al-Qasmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Al-Qasmi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Al-Qasmi

Dr. Mohammed Al-Qasmi is a neurology specialist in Bay City, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Al-Qasmi performed 2,103 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Al-Qasmi received a total of $24,508 from 43 pharmaceutical and/or device companies across 405 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Al-Qasmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 8% volume in MI $24,508 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,103
Medicare services
Top 8% in MI for neurology
Not available
Unique patients (not deduplicated)
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
764 $61 $125
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
383 $88 $175
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
300 $165 $458
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
270 $130 $350
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
129 $92 $150
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
70 $73 $300
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
68 $125 $225
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
35 $38 $100
New patient office visit, complex (60-74 min) 29 $154 $375
Same-day hospital admission and discharge, high complexity
Initial hospital care for a patient admitted and discharged on the same day, involving a high level of medical decision making. This service requires at least 85 minutes of time spent on the day of the visit.
20 $133 $325
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
19 $177 $525
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
16 $215 $600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$24,508
Total received (2018-2024)
Avg $3,501/year across 7 years
Top 14% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
405
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,126
2023
$897
2022
$838
2021
$923
2020
$927
2019
$6,503
2018
$13,295

Payments by company (2024)

UCB, Inc.
$361
ABBVIE INC.
$165
Neurelis, Inc.
$79
Genentech USA, Inc.
$72
Eisai Inc.
$70
PFIZER INC.
$65
Novartis Pharmaceuticals Corporation
$64
Otsuka America Pharmaceutical, Inc.
$59
Neurocrine Biosciences, Inc.
$41
CATALYST PHARMACEUTICALS, INC.
$29
Biogen, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
Lilly USA, LLC
$19
JAZZ PHARMACEUTICALS INC.
$17
Celgene Corporation
$14
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$12,275
Celgene Corporation
$5,708
UCB, Inc.
$1,090
Biogen, Inc.
$829
Novartis Pharmaceuticals Corporation
$602
EMD Serono, Inc.
$509
GENZYME CORPORATION
$380
Neurelis, Inc.
$271
ABBVIE INC.
$240
Teva Pharmaceuticals USA, Inc.
$216
Janssen Pharmaceuticals, Inc
$213
PFIZER INC.
$203
Amgen Inc.
$174
Supernus Pharmaceuticals, Inc.
$173
Acorda Therapeutics, Inc
$163
PORTOLA PHARMACEUTICALS, LLC
$130
AbbVie Inc.
$109
Adamas Pharmaceuticals, Inc.
$108
SK Life Science, Inc.
$99
Eisai Inc.
$88
Sunovion Pharmaceuticals Inc.
$76
Otsuka America Pharmaceutical, Inc.
$75
ACADIA Pharmaceuticals Inc
$73
Harmony Biosciences LLC
$72
Allergan Inc.
$66
Lilly USA, LLC
$64
Neurocrine Biosciences, Inc.
$56
Avanir Pharmaceuticals, Inc.
$52
Horizon Therapeutics plc
$50
Alexion Pharmaceuticals, Inc.
$43
Allergan, Inc.
$39
Nevro Corp.
$35
LivaNova USA, Inc.
$34
CATALYST PHARMACEUTICALS, INC.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$24
Vanda Pharmaceuticals Inc.
$22
Lundbeck LLC
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
EISAI INC.
$20
JAZZ PHARMACEUTICALS INC.
$17
ITI, Inc.
$15
Zyla Life Sciences
$14
Mitsubishi Tanabe Pharma America, Inc.
$13
Top 3 companies account for 77.8% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · BOTOX · Briviact · CAPLYTA · COMIRNATY · COPAXONE · EMGALITY · EPIDIOLEX · Enspryng · FYCOMPA · Fanapt · Fintepla · GILENYA · GOCOVRI · HYQVIA · INBRIJA · INGREZZA · KESIMPTA · LATUDA · LEMTRADA · LYRICA · Leqembi · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · OXTELLAR XR · Ocrevus · Ozanimod · Ponvory · QULIPTA · RADICAVA · REXULTI · Radicava · Rebif · Rystiggo · SKYCLARYS · SPRIX · Senza · Soliris · TECFIDERA · TOVIAZ · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · Wakix · XARELTO · XCOPRI · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Bay City?
Compare neurologists in the Bay City area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
17
County median income
$60,523
Nearest hospital to ZIP centroid (approximate)
MCLAREN BAY REGION
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Al-Qasmi is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MI), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Al-Qasmi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Al-Qasmi performed 764 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Al-Qasmi receive payments from pharmaceutical companies?
Yes. Dr. Al-Qasmi received a total of $24,508 from 43 companies across 405 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Al-Qasmi's costs compare to other neurologists in Bay City?
Dr. Al-Qasmi's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Al-Qasmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →